| 000 | 01436 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518065543.0 | ||
| 264 | 0 | _c20200420 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a1873-3476 | ||
| 024 | 7 |
_a10.1016/j.ijpharm.2019.118775 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSabra, Rayan | |
| 245 | 0 | 0 |
_aCetuximab-conjugated chitosan-pectinate (modified) composite nanoparticles for targeting colon cancer. _h[electronic resource] |
| 260 |
_bInternational journal of pharmaceutics _cDec 2019 |
||
| 300 |
_a118775 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xchemistry |
| 650 | 0 | 4 | _aCaco-2 Cells |
| 650 | 0 | 4 |
_aCell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCetuximab _xchemistry |
| 650 | 0 | 4 |
_aChitosan _xchemistry |
| 650 | 0 | 4 |
_aColonic Neoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aCurcumin _xchemistry |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aDrug Liberation _xphysiology |
| 650 | 0 | 4 |
_aG2 Phase Cell Cycle Checkpoints _xdrug effects |
| 650 | 0 | 4 | _aHCT116 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aNanoparticles _xchemistry |
| 650 | 0 | 4 |
_aPectins _xchemistry |
| 700 | 1 | _aBilla, Nashiru | |
| 700 | 1 | _aRoberts, Clive J | |
| 773 | 0 |
_tInternational journal of pharmaceutics _gvol. 572 _gp. 118775 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.ijpharm.2019.118775 _zAvailable from publisher's website |
| 999 |
_c30265216 _d30265216 |
||